Latest Breast biopsy Stories
New FDA Clearance Allows for the Ability of the Intact® Technology to Preserve Breast Lesion Architecture; Making a Reduction in Open Surgical Procedures a Potential FRAMINGHAM, Mass.,
BUFFALO GROVE, Illinois, December 4, 2014 /PRNewswire/ -- Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today
BUFFALO GROVE, Illinois, October 28, 2014 /PRNewswire/ -- Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today
Stephen MacMillan, Hologic President and CEO, to highlight the important benefits of Hologic's 3D Mammography solution for breast cancer screening and diagnosis BEDFORD, Mass., Sept.
Hologic 3D and 2D mammography systems ranked first and second place respectively in annual independent survey of healthcare providers worldwide by KLAS Research BEDFORD, Mass., Sept.
With just under 60% of the amount spent in the U.S., European health authorities bought close to 500,000 more biopsy needles for breast cancer treatment and prevention.
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Study using Hologic 3D Mammography systems is the largest to date involving 139 doctors from 13 U.S.
Hologic's low-dose 3D mammography and 3D-guided breast biopsy are highlighted at annual recognition event BEDFORD, Mass., June 11, 2014 /PRNewswire/ -- Hologic, Inc.
Needle biopsy, the standard of care radiological procedure for diagnosing breast cancer, is underused with too many patients undergoing the more invasive, excisional biopsy to detect their disease.